
siRNA/miRNA Synthesis Service is a professional service that provides small interfering RNA and microRNA synthesis. This service is suitable for molecular biology research and gene expression regulation experiments. By synthesizing siRNA or miRNA of specific sequences, researchers can effectively target and silence specific genes. This service has important applications in basic research and drug development. The synthesis services provided usually have high purity and high efficiency to meet different research needs.
The global siRNA/miRNA Synthesis Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for siRNA/miRNA Synthesis Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for siRNA/miRNA Synthesis Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for siRNA/miRNA Synthesis Service in University is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of siRNA/miRNA Synthesis Service include Synbio-Tech, Horizo​​n Discovery, Bioneer, Creative-Biolabs, Genecfps, Generay, Genscript, Sangon Biotech, Omics Bio, Beijing Tsingke Biotech, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for siRNA/miRNA Synthesis Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding siRNA/miRNA Synthesis Service.
The siRNA/miRNA Synthesis Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global siRNA/miRNA Synthesis Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the siRNA/miRNA Synthesis Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Synbio-Tech
Horizo​​n Discovery
Bioneer
Creative-Biolabs
Genecfps
Generay
Genscript
Sangon Biotech
Omics Bio
Beijing Tsingke Biotech
Creative Biogene Biotechnology
Segment by Type
Custom siRNA/miRNA Synthesis Service
Ordinary siRNA/miRNA Synthesis Service
Segment by Application
University
Research Institute
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of siRNA/miRNA Synthesis Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global siRNA/miRNA Synthesis Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Custom siRNA/miRNA Synthesis Service
1.2.3 Ordinary siRNA/miRNA Synthesis Service
1.3 Market by Application
1.3.1 Global siRNA/miRNA Synthesis Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 University
1.3.3 Research Institute
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global siRNA/miRNA Synthesis Service Market Perspective (2019-2030)
2.2 Global siRNA/miRNA Synthesis Service Growth Trends by Region
2.2.1 Global siRNA/miRNA Synthesis Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 siRNA/miRNA Synthesis Service Historic Market Size by Region (2019-2024)
2.2.3 siRNA/miRNA Synthesis Service Forecasted Market Size by Region (2025-2030)
2.3 siRNA/miRNA Synthesis Service Market Dynamics
2.3.1 siRNA/miRNA Synthesis Service Industry Trends
2.3.2 siRNA/miRNA Synthesis Service Market Drivers
2.3.3 siRNA/miRNA Synthesis Service Market Challenges
2.3.4 siRNA/miRNA Synthesis Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top siRNA/miRNA Synthesis Service Players by Revenue
3.1.1 Global Top siRNA/miRNA Synthesis Service Players by Revenue (2019-2024)
3.1.2 Global siRNA/miRNA Synthesis Service Revenue Market Share by Players (2019-2024)
3.2 Global siRNA/miRNA Synthesis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by siRNA/miRNA Synthesis Service Revenue
3.4 Global siRNA/miRNA Synthesis Service Market Concentration Ratio
3.4.1 Global siRNA/miRNA Synthesis Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by siRNA/miRNA Synthesis Service Revenue in 2023
3.5 Global Key Players of siRNA/miRNA Synthesis Service Head office and Area Served
3.6 Global Key Players of siRNA/miRNA Synthesis Service, Product and Application
3.7 Global Key Players of siRNA/miRNA Synthesis Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 siRNA/miRNA Synthesis Service Breakdown Data by Type
4.1 Global siRNA/miRNA Synthesis Service Historic Market Size by Type (2019-2024)
4.2 Global siRNA/miRNA Synthesis Service Forecasted Market Size by Type (2025-2030)
5 siRNA/miRNA Synthesis Service Breakdown Data by Application
5.1 Global siRNA/miRNA Synthesis Service Historic Market Size by Application (2019-2024)
5.2 Global siRNA/miRNA Synthesis Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America siRNA/miRNA Synthesis Service Market Size (2019-2030)
6.2 North America siRNA/miRNA Synthesis Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America siRNA/miRNA Synthesis Service Market Size by Country (2019-2024)
6.4 North America siRNA/miRNA Synthesis Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe siRNA/miRNA Synthesis Service Market Size (2019-2030)
7.2 Europe siRNA/miRNA Synthesis Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe siRNA/miRNA Synthesis Service Market Size by Country (2019-2024)
7.4 Europe siRNA/miRNA Synthesis Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific siRNA/miRNA Synthesis Service Market Size (2019-2030)
8.2 Asia-Pacific siRNA/miRNA Synthesis Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific siRNA/miRNA Synthesis Service Market Size by Region (2019-2024)
8.4 Asia-Pacific siRNA/miRNA Synthesis Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America siRNA/miRNA Synthesis Service Market Size (2019-2030)
9.2 Latin America siRNA/miRNA Synthesis Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America siRNA/miRNA Synthesis Service Market Size by Country (2019-2024)
9.4 Latin America siRNA/miRNA Synthesis Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa siRNA/miRNA Synthesis Service Market Size (2019-2030)
10.2 Middle East & Africa siRNA/miRNA Synthesis Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa siRNA/miRNA Synthesis Service Market Size by Country (2019-2024)
10.4 Middle East & Africa siRNA/miRNA Synthesis Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Synbio-Tech
11.1.1 Synbio-Tech Company Details
11.1.2 Synbio-Tech Business Overview
11.1.3 Synbio-Tech siRNA/miRNA Synthesis Service Introduction
11.1.4 Synbio-Tech Revenue in siRNA/miRNA Synthesis Service Business (2019-2024)
11.1.5 Synbio-Tech Recent Development
11.2 Horizo​​n Discovery
11.2.1 Horizo​​n Discovery Company Details
11.2.2 Horizo​​n Discovery Business Overview
11.2.3 Horizo​​n Discovery siRNA/miRNA Synthesis Service Introduction
11.2.4 Horizo​​n Discovery Revenue in siRNA/miRNA Synthesis Service Business (2019-2024)
11.2.5 Horizo​​n Discovery Recent Development
11.3 Bioneer
11.3.1 Bioneer Company Details
11.3.2 Bioneer Business Overview
11.3.3 Bioneer siRNA/miRNA Synthesis Service Introduction
11.3.4 Bioneer Revenue in siRNA/miRNA Synthesis Service Business (2019-2024)
11.3.5 Bioneer Recent Development
11.4 Creative-Biolabs
11.4.1 Creative-Biolabs Company Details
11.4.2 Creative-Biolabs Business Overview
11.4.3 Creative-Biolabs siRNA/miRNA Synthesis Service Introduction
11.4.4 Creative-Biolabs Revenue in siRNA/miRNA Synthesis Service Business (2019-2024)
11.4.5 Creative-Biolabs Recent Development
11.5 Genecfps
11.5.1 Genecfps Company Details
11.5.2 Genecfps Business Overview
11.5.3 Genecfps siRNA/miRNA Synthesis Service Introduction
11.5.4 Genecfps Revenue in siRNA/miRNA Synthesis Service Business (2019-2024)
11.5.5 Genecfps Recent Development
11.6 Generay
11.6.1 Generay Company Details
11.6.2 Generay Business Overview
11.6.3 Generay siRNA/miRNA Synthesis Service Introduction
11.6.4 Generay Revenue in siRNA/miRNA Synthesis Service Business (2019-2024)
11.6.5 Generay Recent Development
11.7 Genscript
11.7.1 Genscript Company Details
11.7.2 Genscript Business Overview
11.7.3 Genscript siRNA/miRNA Synthesis Service Introduction
11.7.4 Genscript Revenue in siRNA/miRNA Synthesis Service Business (2019-2024)
11.7.5 Genscript Recent Development
11.8 Sangon Biotech
11.8.1 Sangon Biotech Company Details
11.8.2 Sangon Biotech Business Overview
11.8.3 Sangon Biotech siRNA/miRNA Synthesis Service Introduction
11.8.4 Sangon Biotech Revenue in siRNA/miRNA Synthesis Service Business (2019-2024)
11.8.5 Sangon Biotech Recent Development
11.9 Omics Bio
11.9.1 Omics Bio Company Details
11.9.2 Omics Bio Business Overview
11.9.3 Omics Bio siRNA/miRNA Synthesis Service Introduction
11.9.4 Omics Bio Revenue in siRNA/miRNA Synthesis Service Business (2019-2024)
11.9.5 Omics Bio Recent Development
11.10 Beijing Tsingke Biotech
11.10.1 Beijing Tsingke Biotech Company Details
11.10.2 Beijing Tsingke Biotech Business Overview
11.10.3 Beijing Tsingke Biotech siRNA/miRNA Synthesis Service Introduction
11.10.4 Beijing Tsingke Biotech Revenue in siRNA/miRNA Synthesis Service Business (2019-2024)
11.10.5 Beijing Tsingke Biotech Recent Development
11.11 Creative Biogene Biotechnology
11.11.1 Creative Biogene Biotechnology Company Details
11.11.2 Creative Biogene Biotechnology Business Overview
11.11.3 Creative Biogene Biotechnology siRNA/miRNA Synthesis Service Introduction
11.11.4 Creative Biogene Biotechnology Revenue in siRNA/miRNA Synthesis Service Business (2019-2024)
11.11.5 Creative Biogene Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Synbio-Tech
Horizo​​n Discovery
Bioneer
Creative-Biolabs
Genecfps
Generay
Genscript
Sangon Biotech
Omics Bio
Beijing Tsingke Biotech
Creative Biogene Biotechnology
Ìý
Ìý
*If Applicable.
